AI Day1 LLC Exits Position in Day One Biopharmaceuticals via Tender Offer

AI Day1 LLC, alongside Access Industries Holdings LLC, Access Industries Management, LLC, and Len Blavatnik, filed Amendment No. 6 to Schedule 13D, reporting the complete liquidation of their position in Day One Biopharmaceuticals, Inc. (DAWN). On April 9, 2026, AI Day1 tendered all of its common stock shares in response to a tender offer by Servier Detroit Inc. (Purchaser) at a price of $21.50 per share in cash. These shares were officially accepted by the Purchaser on April 23, 2026. Additionally, in connection with the merger's consummation, pre-funded warrants held by the filer were converted into cash at $21.4999 per warrant. Consequently, as of April 23, 2026, the Reporting Persons ceased to be beneficial owners of more than five percent of the company's common stock and currently hold zero shares. This filing marks the final exit of AI Day1 LLC and its affiliates from their significant investment in the issuer following the acquisition by Servier.